nrc

AN-019 (NRC-019) 是一种 Bcr-Abl 激酶抑制剂， 具有抗肿瘤活性，可用于研究慢性粒细胞白血病（CML）和乳腺癌。

NRC-2694 是表皮生长因子受体的有效拮抗剂，具抗增殖、有抗癌的活性。

NRC-2694 dihydrochloride is an epidermal growth factor receptor (EGFR) antagonist potentially for the treatment of solid tumors.

NRC-2694 hydrochloride is an epidermal growth factor receptor (EGFR) antagonist potentially for the treatment of solid tumors.

NRC-16为具有生物活性的肽，属于(杀侧耳素样阳离子AMP)类化合物。

Bexin-1 is an inhibitor of Munc13-4 membrane binding which targets the Munc13-4 C2 domain-membrane interface, and inhibits ionomycin-stimulated ANF-EGFP secretion.

ID110460002 is a novel μ,δ-Opioid Receptor Dual-Biased Agonist, Overcoming the Limitation of Prior Biased Agonist.

Zonisamide (AD 810) 是锌酶碳酸酐酶 (carbonic anhydrase) 的有效抑制剂，对人类线粒体同工酶 hCA II 和 hCA V 作用的 Ki 值分别为 35.2 nM 和 20.6 nM。Zonisamide 具有抗癫痫活性，在癫痫、癫痫发作和帕金森病的研究中具有价值。

Somatostatin RC 102 is a peptide hormone. It regulates the endocrine system and affects neurotransmission and cell proliferation via interaction with G protein-coupled somatostatin receptors and inhibition of the release of numerous secondary hormones.

SARS-CoV-2-IN-79 (Compound 5) 是一种能够抑制SARS-CoV-2的化合物，其IC50值为55 μg/mL，CC50值为311.6 μg/mL。此化合物在(hCoV-19/Egypt/NRC-03/2020)中表现出最显著的抗病毒活性，可用于COVID-19相关研究。